Press "Enter" to skip to content

USFDA makes 22 observations post inspection of Lupin’s Mandideep facilities

Lupin said the observations are "largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalosporin API blockā€ and the company is confident of addressing them satisfactorily.

Original source: https://health.economictimes.indiatimes.com/news/pharma/usfda-makes-22-observations-post-inspection-of-lupins-mandideep-facilities/66952684?utm_source=RSS&utm_medium=ETRSS

Also Read:   Pfizer to raise US drug prices in January after previously backing down